Trial
NCT02966002
Aspirin as a Novel Anti-Inflammatory Modality in the Fontan Patients
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Michigan
Collaborators
—
Condition
Fontan Procedure
Intervention
Aspirin
Why stopped
This study was terminated due to inability to recruit sufficient patients.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-18